Mirati Therapeutics Statistics Share Statistics Mirati Therapeutics has 70.15M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 70.15M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 38.91M Failed to Deliver (FTD) Shares 100 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 2.56M, so 0% of the outstanding
shares have been sold short.
Short Interest 2.56M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 2.32
Valuation Ratios The PE ratio is -3.44 and the forward
PE ratio is null.
Mirati Therapeutics's PEG ratio is
-0.2.
PE Ratio -3.44 Forward PE n/a PS Ratio 204.88 Forward PS n/a PB Ratio 2.56 P/FCF Ratio -4.43 PEG Ratio -0.2
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Mirati Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.96,
with a Debt / Equity ratio of 0.05.
Current Ratio 6.96 Quick Ratio 6.94 Debt / Equity 0.05 Debt / EBITDA -0.07 Debt / FCF -0.09 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $21.19K Profits Per Employee $-1.26M Employee Count 587 Asset Turnover 0.01 Inventory Turnover 0.2
Taxes Income Tax 508K Effective Tax Rate -0.07%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0.77, so Mirati Therapeutics's
price volatility has been higher than the market average.
Beta 0.77 52-Week Price Change n/a 50-Day Moving Average 57.75 200-Day Moving Average 45.58 Relative Strength Index (RSI) 56.14 Average Volume (20 Days) 1,778,618
Income Statement In the last 12 months, Mirati Therapeutics had revenue of 12.44M
and earned -740.87M
in profits. Earnings per share was -13.18.
Revenue 12.44M Gross Profit 11.84M Operating Income -759.59M Net Income -740.87M EBITDA -756.66M EBIT -758.32M Earnings Per Share (EPS) -13.18
Full Income Statement Balance Sheet The company has 235.26M in cash and 51.51M in
debt, giving a net cash position of 183.75M.
Cash & Cash Equivalents 235.26M Total Debt 51.51M Net Cash 183.75M Retained Earnings -2.45B Total Assets 1.13B Working Capital 898.7M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -570.57M
and capital expenditures -4.85M, giving a free cash flow of -575.42M.
Operating Cash Flow -570.57M Capital Expenditures -4.85M Free Cash Flow -575.42M FCF Per Share -10.23
Full Cash Flow Statement Margins Gross margin is 95.18%, with operating and profit margins of -6107.98% and -5957.44%.
Gross Margin 95.18% Operating Margin -6107.98% Pretax Margin -5953.35% Profit Margin -5957.44% EBITDA Margin -6084.43% EBIT Margin -6107.98% FCF Margin -4627.06%
Dividends & Yields MRTX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for MRTX.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 3, 2013. It was a
backward
split with a ratio of 1:50.
Last Split Date Jul 3, 2013 Split Type backward Split Ratio 1:50
Scores Altman Z-Score 8.55 Piotroski F-Score 3
